AstraZeneca boss plays down Teva rumours
AstraZeneca
10,024.00p
17:15 19/11/24
AstraZeneca chief executive Pascal Soriot has played down recent rumours that he was to leave the London-listed drug giant for Israeli generic colossus Teva.
FTSE 100
8,099.02
17:14 19/11/24
FTSE 350
4,469.52
16:34 19/11/24
FTSE All-Share
4,427.06
16:59 19/11/24
Pharmaceuticals & Biotechnology
19,328.21
16:34 19/11/24
The French-born executive, who has led the FTSE 100 company since 2012, told staff in an internal memo that he expected to work "together" with them to see the company succeed, Reuters reported on Friday.
Rumours were "part of everyday business", Soriot said, and the company has stood firm on its policy of not commenting on speculation.
A week ago, Tel Aviv-based Teva, the world's biggest generic drugmaker, was said to be close to naming Soriot as its new CEO and that he had met Teva's chairman and agreed to take the role.
Teva has been without a permanent CEO since February, when Erez Vigodman stepped down, with its chief financial also resigning last month.